Mechanisms of mechanical overload-induced skeletal muscle hypertrophy: current understanding and future directions
- PMID: 37382939
- PMCID: PMC10625844
- DOI: 10.1152/physrev.00039.2022
Mechanisms of mechanical overload-induced skeletal muscle hypertrophy: current understanding and future directions
Abstract
Mechanisms underlying mechanical overload-induced skeletal muscle hypertrophy have been extensively researched since the landmark report by Morpurgo (1897) of "work-induced hypertrophy" in dogs that were treadmill trained. Much of the preclinical rodent and human resistance training research to date supports that involved mechanisms include enhanced mammalian/mechanistic target of rapamycin complex 1 (mTORC1) signaling, an expansion in translational capacity through ribosome biogenesis, increased satellite cell abundance and myonuclear accretion, and postexercise elevations in muscle protein synthesis rates. However, several lines of past and emerging evidence suggest that additional mechanisms that feed into or are independent of these processes are also involved. This review first provides a historical account of how mechanistic research into skeletal muscle hypertrophy has progressed. A comprehensive list of mechanisms associated with skeletal muscle hypertrophy is then outlined, and areas of disagreement involving these mechanisms are presented. Finally, future research directions involving many of the discussed mechanisms are proposed.
Keywords: hypertrophy; mechanical overload; myofiber; resistance training; skeletal muscle.
Conflict of interest statement
M.D.R. has received funding in the form of contracts, gifts, and grants from industry sources, Auburn University (Intramural Grants Program), and the Peanut Institute (commodities) for work in certain areas discussed in this article. S.M.P. has patent (Canadian) 3052324 assigned to Exerkine and patent (US) 20200230197 pending to Exerkine but reports no financial gains from any patent or related work. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- U01AG055137/AG/NIA NIH HHS/United States
- AR079220/AR/NIAMS NIH HHS/United States
- U01 AG055137/AG/NIA NIH HHS/United States
- AG069909/AG/NIA NIH HHS/United States
- R01 DK119619/DK/NIDDK NIH HHS/United States
- R01AR074932/AR/NIAMS NIH HHS/United States
- R01 AR072735/AR/NIAMS NIH HHS/United States
- R01 AR078430/AR/NIAMS NIH HHS/United States
- R01 AR074932/AR/NIAMS NIH HHS/United States
- AR072735/AR/NIAMS NIH HHS/United States
- R01 AR079220/AR/NIAMS NIH HHS/United States
- F32 AR072481/AR/NIAMS NIH HHS/United States
- DK119619/DK/NIDDK NIH HHS/United States
- R01 AG069909/AG/NIA NIH HHS/United States
- AR078430/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous
